We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Malignant neoplasms of respiratory and intrathoracic organs
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
This is a phase III randomized trial comparing sublobar resection to SAbR radiation in high risk stage I lung cancer patients. The purpose of the study is to confirm which procedure is more effective and safer. In order to confirm this patients will be 1:1 randomised to one of these procedures and then subsequently monitored to assess their health outcomes (specifically survival data and side effects) which will include visits 4 weeks after treatment then every 3 months for 2 years, then every 6 months for 3 more years. If patients decline to be randomised to one of the treatments we will still ask if they are happy for their data to be collected to aid the study analysis.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Type: Radiotherapy;Surgery;
You can take part if:
You may not be able to take part if:
Do not satisfy the inclusion criteria
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
The study is sponsored by SOUTH TEES HOSPITALS NHS FOUNDATION TRUST and funded by The University of Texas Southwestern Medical Center .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 47075
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
